A woman aged 18 years of age was brought to the emergency department due to an acute change in mental status after taking 2.85 g sustained release bupropion 1.5 hours earlier. On presentation, she was disoriented and could not follow verbal orders. The other neurologic and physical examinations were unremarkable. Initial blood pressure was 84/36 mm Hg, heart rate was 121 beats per minute, respiration rate was 19 breaths per minute, and her body temperate was 36.8 C. Electrocardiography (ECG) revealed sinus tachycardia with QRS duration of 100 ms and corrected QT interval of 550 ms. Serum biochemistry showed severe metabolic acidosis (pH 6.82; PaCO 2 54.8 kPa; PaO 2 85 kPa; HCO 3 9.2 mmol/l). Intravenous saline with sodium bicarbonate (50 mEq) was given, and gastric lavage found no pill fragment returned. Four episodes of generalized tonic-clonic seizure occurred, lasting for 15w60 seconds, and we gave multiple doses of diazepam and phenytoin for control. Brain computed tomography did not find any structural abnormality or hemorrhage. At 5 hours postingestion, bradycardia occurred after the fifth seizure episode, with degeneration to pulseless ventricular tachycardia, and she recovered after 10 minutes of cardiopulmonary resuscitation. She was admitted to an intensive care unit and had two additional seizure attacks. We started charcoal hemoperfusion at 9 hours postingestion, and her status epilepticus resolved with regained consciousness within 8 hours of therapy. QTc prolongation also recovered at about 16 hours postingestion (450 ms). She was extubated the same day and discharged on Day 9 of hospitalization after undergoing psychiatric consultation, and she did not have any further seizures or cardiovascular events.
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QTc prolongation is gradually recognized as a rare presentation of bupropion intoxication. There are several case reports of bupropion overdose associated QTc prolongation (Table 1) , 1e5 and the duration of prolongation in most cases exceeds 48 hours after supportive management (gastric lavage and sodium bicarbonate). A 20-year MEDLINE search reveals only two bupropion poisoning cases with status epilepticus and concurrent QTc prolongation. 1, 2 Both of them received supportive management only and had longer duration of QTc prolongation than our patient, despite lower dose ingested in one case. 1 In our patient, the QTc prolongation recovered at 16 hours postingestion after charcoal hemoperfusion, which had not been reported previously as a therapeutic option. As a lipid soluble substance with large apparent volume of distribution (19 AE 9 L/kg), bupropion theoretically would not be extracted efficiently by charcoal hemoperfusion. However, Bek and others paradoxically reported charcoal hemoperfusion as an effective treatment modality for amitriptyline poisoning. 6 They speculated that the toxicokinetics of Tricyclic antidepressant (TCA) might differ from usual pharmacokinetics and may be substantially altered during severe intoxication, which favors extracorporeal removal. Marked elevated drug level above therapeutic range probably decreased both the volume of distribution and degree of protein binding by TCA. This provides a plausible explanation for the rapid recovery of ECG abnormality and the fair outcome in our patient. Therefore, charcoal hemoperfusion may work in a similar way to manage severe bupropion intoxication with status epilepticus. Nevertheless, a complete pharmacokinetic study is still warranted to evaluate the efficacy of hemoperfusion as a therapeutic modality for treating severe, seizure-prone bupropion overdose. 
